news you can use… pete koval, pharmd megan shah, pharmd candidate cone health family medicine july...

7
News You Can Use… Pete Koval, PharmD Megan Shah, PharmD Candidate Cone Health Family Medicine July 2015

Upload: stella-sims

Post on 25-Dec-2015

215 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: News You Can Use… Pete Koval, PharmD Megan Shah, PharmD Candidate Cone Health Family Medicine July 2015

News You Can Use…

Pete Koval, PharmD

Megan Shah, PharmD Candidate

Cone Health Family Medicine

July 2015

Page 2: News You Can Use… Pete Koval, PharmD Megan Shah, PharmD Candidate Cone Health Family Medicine July 2015

Drug Launched

• Risedronate, generic for Actonel, is now available• Risedronate is used for the treatment and

prevention of osteoporosis and treatment of Paget’s disease.

• Available as 5 mg, 30 mg, and 35 mg tablets

06/2/2015 Pharmacy Times

Page 3: News You Can Use… Pete Koval, PharmD Megan Shah, PharmD Candidate Cone Health Family Medicine July 2015

Trial Review

• IMPROVE-IT trial shows cardiac benefit of adding ezetimibe 10 mg to simvastatin 40 mg after ACS• Simvastatin/ezetimibe reduced CV events by

~7% vs. simvastatin monotherapy (NNT=50)• Baseline LDL of 94 mg/dl was reduced to 54

g/dl with simvastatin/ezetimibe and 70 mg/dl with simvastatin alone.

06/4/2015 N Engl J Med

Page 4: News You Can Use… Pete Koval, PharmD Megan Shah, PharmD Candidate Cone Health Family Medicine July 2015

Pharmacy Business

• CVS Health bought Target pharmacies and clinics• Target pharmacies will operate under CVS

name inside Target stores.• Target clinics will be rebranded as

MinuteClinic

06/15/2015 NY Times

Page 5: News You Can Use… Pete Koval, PharmD Megan Shah, PharmD Candidate Cone Health Family Medicine July 2015

New Indication

• Zomig (zolmitriptan) nasal spray has been FDA approved for treatment of migraines with or without aura in pediatric patients >12 years of age• Previously was only indicated for age >18.• Starting dose for pediatric patients is 2.5 mg

daily with a max dose of 10 mg daily.

06/16/2015 Medscape

Page 6: News You Can Use… Pete Koval, PharmD Megan Shah, PharmD Candidate Cone Health Family Medicine July 2015

New Drug Approval

• Kengreal (cangrelor) gained FDA approval to prevent blood clots in patients undergoing PCI• Intravenous antiplatelet drug (P2Y12

inhibitor)• Administered as a 30 mcg/kg bolus injection,

followed by a 4 mcg/kg/min infusion for 2 to 4 hours.

06/22/2015 FDA.gov

Page 7: News You Can Use… Pete Koval, PharmD Megan Shah, PharmD Candidate Cone Health Family Medicine July 2015

FDA Warning

• FDA issued a warning of permanent loss of skin color for Daytrana (methylphenidate) patch.• Skin condition is called chemical leukoderma• Time of onset ranges from 2 months to 4

years

06/24/2015 FDA.gov